These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2976170)
21. Evidence for medial-mass regression in the vascular wall of Dahl hypertensive rats by cicletanine treatment. Uehara Y; Numabe A; Kawabata Y; Nagata T; Iwai J; Matsuoka H; Yagi S; Takabatake Y; Sugimoto T J Cardiovasc Pharmacol; 1991 Jul; 18(1):158-66. PubMed ID: 1719285 [TBL] [Abstract][Full Text] [Related]
22. Modification of the antihypertensive effect of indapamide by indomethacin. Pasnani JS; Gulati OD; Hemavathi KG Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038 [TBL] [Abstract][Full Text] [Related]
23. Further evidence for a peripheral sympathicolytic action of the antihypertensive cicletanine in rats. Castro A; Hernando F; Parra L; Puerro M; Aleixandre A; Fuentes JA Drugs Exp Clin Res; 1995; 21(1):29-36. PubMed ID: 7796710 [TBL] [Abstract][Full Text] [Related]
24. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system. Bippi H; Guinot P Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine. Silver PJ; Buchholz A; Dundore RL; Harris AL; Pagani ED J Cardiovasc Pharmacol; 1990 Sep; 16(3):501-5. PubMed ID: 1700224 [TBL] [Abstract][Full Text] [Related]
26. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanism of action of the antihypertensive agent cicletanine. Castro A; Parra L; Fuentes JA Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():51-4. PubMed ID: 2514669 [TBL] [Abstract][Full Text] [Related]
28. Effect of cicletanine on renal cGMP production. Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive effect of cicletanine is exaggerated in NaCl-sensitive hypertension. Jin HK; Yang RH; Esunge P; Chen YF; Durand J; Oparil S Am J Med Sci; 1991 Jun; 301(6):383-9. PubMed ID: 1645501 [TBL] [Abstract][Full Text] [Related]
30. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects. Richard V; Joannides R; Henry JP; Mulder P; Mace B; Guez D; Schiavi P; Thuillez C J Hypertens; 1996 Dec; 14(12):1447-54. PubMed ID: 8986928 [TBL] [Abstract][Full Text] [Related]
31. Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment. Doucet J; Richard V; Mulder P; Henry JP; Schiavi P; Guez D; Thuillez C J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):107-11. PubMed ID: 11881108 [TBL] [Abstract][Full Text] [Related]
32. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats. Miquel R; Gisbert R; Serna E; Perez-Vizcaino F; Anselmi E; Noguera MA; Ivorra MD; D'Ocon MP J Pharmacol Exp Ther; 2005 Apr; 313(1):359-67. PubMed ID: 15615866 [TBL] [Abstract][Full Text] [Related]
33. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
34. Further study of possible direct vascular actions of indapamide in the conduit and renal arteriolar vessels of spontaneously hypertensive rats. De Wildt DJ; Van de Kuil A; Hillen FC; De Groot G Eur J Pharmacol; 1988 Mar; 147(3):327-34. PubMed ID: 3378562 [TBL] [Abstract][Full Text] [Related]
35. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195 [TBL] [Abstract][Full Text] [Related]
36. Antihypertensive action of indapamide. Comparative studies in several experimental models. Kyncl J; Oheim K; Seki T; Solles A Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026 [TBL] [Abstract][Full Text] [Related]
37. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism. Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190 [TBL] [Abstract][Full Text] [Related]
38. Cicletanine improves myocardial function deteriorated by ischemia/reperfusion in isolated working rat hearts. Ferdinandy P; Koltai M; Tosaki A; Berthet P; Tarrade T; Esanu A; Braquet P J Cardiovasc Pharmacol; 1992 Feb; 19(2):181-9. PubMed ID: 1376786 [TBL] [Abstract][Full Text] [Related]
39. Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats. Gisbert R; Ziani K; Miquel R; Noguera MA; Ivorra MD; Anselmi E; D'Ocon P Br J Pharmacol; 2002 Jan; 135(1):206-16. PubMed ID: 11786496 [TBL] [Abstract][Full Text] [Related]
40. The effect of cicletanine on cerebrovascular injury in stroke-prone spontaneously hypertensive rats. Ruchoux MM; Huguet F; Droy-Lefaix MT; Gelot A; Ruchoux P; Autret A Am J Hypertens; 1989 Sep; 2(9):683-9. PubMed ID: 2803675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]